07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
A Hollywood union’s recent amendments to its union rules has sparked federal antitrust lawsuits by ...
Read More >
ANTITRUST AND COMPETITION - The Court Of Justice Of The EU Confirms The Legality Of Certain Commissi...
Read More >
Every CEQA analysis begins with the threshold question of whether the activity is a “project” as d...
Read More >
The FTC published its views on divestiture packages used to obtain clearance under the HSR Act. Acc...
Read More >
It kind of goes without saying, but you should probably bring your expert to a dispute if there is g...
Read More >
Proskauer’s 24th Annual Trick or Treat Seminar was held on Wednesday, October 31 and discussed time...
Read More >